Rebound acid hypersecretion from a physiological, pathophysiological and clinical viewpoint.

Waldum, Helge L; Qvigstad, Gunnar; Fossmark, Reidar; Kleveland, Per M; Sandvik, Arne K

Waldum, Helge L; Qvigstad, Gunnar; Fossmark, Reidar; Kleveland, Per M; Sandvik, Arne K.

Affiliation

Waldum HL; Department of Gastroenterology and Liver Diseases, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway. helge.waldum@ntnu.no

Scand J Gastroenterol ; 45(4): 389-94, 2010 Apr.

Article in En | MEDLINE | ID: mdl-20001749

Subject(s)

Dyspepsia/etiology; Enterochromaffin-like Cells/metabolism; Gastric Acid/metabolism; Gastroesophageal Reflux/drug therapy; Proton Pump Inhibitors/administration & dosage; Animals; Gastrinoma/metabolism; Gastroesophageal Reflux/metabolism; Helicobacter Infections/metabolism; Helicobacter pylori; Histamine/metabolism; Histamine H2 Antagonists/administration & dosage; Humans; Parietal Cells, Gastric/metabolism; Rats; Stomach Neoplasms/metabolism

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastroesophageal Reflux / Enterochromaffin-like Cells / Dyspepsia / Proton Pump Inhibitors / Gastric Acid Limits: Animals / Humans Language: En Journal: Scand J Gastroenterol Year: 2010 Document type: Article

Fulltext

XML

PubMed Links

Search on Google